Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C - sprookjes - yvandenbroek - TriplyDB

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

http://www.wikidata.org/entity/Q27477966

about

NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations Hepatitis C Virus, Insulin Resistance, and Steatosis Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Mechanisms and significance of liver steatosis in hepatitis C virus infection Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial Changes in lipid metabolism in chronic hepatitis C.Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B Fibrosis progression in chronic hepatitis C virus infection.Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.Hepatitis C virus-induced hepatocellular steatosis.Hepatitis C virus infection: Are there still specific problems with genotype 3?Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link.Hepatitis C and steatosis: a reappraisal.Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C MTP -493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients.Hepatitis C and diabetes: the inevitable coincidence?Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy.Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis.Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis.Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases

P2860

Q26745576-7A5AC2F4-FD6C-4846-B681-643D59C72F39 Q26751755-CB69D8FB-14B3-4C61-8C0E-0CFB45E688B4 Q26861095-AB526183-78D5-4BDE-8B0E-D66033EC3746 Q27478329-59998877-1D29-4A4E-95EC-651C1D1599EE Q30360538-477DAAEF-06E7-4E80-B644-7A6F6FA31F8C Q33866272-58AF0836-F279-4173-956E-372E240ED114 Q35098353-1302D80C-A662-4314-9EDA-09C6E74CCB6C Q35142681-19283A60-0947-4AAE-9B12-99034F1E02C5 Q35165949-0654BF0A-5392-4E41-8F27-5B653A4412F5 Q35555702-91282FB5-7C0F-4BFE-B52E-83412267EA74 Q35666213-610860AC-171F-40E8-B74D-43BE32627B1E Q35761351-78220981-B835-4CE9-ABAE-A5289B99A11C Q36060022-52103716-DAD7-40DA-A496-2B74CAADDD9F Q36269670-1395D01C-2A89-43A3-B3B9-6298005ED6B0 Q36286323-60675515-FA3B-4057-88B8-E796CD75A176 Q36377276-C58E1409-2E53-4E34-A9FA-2FCE8DEFCAE7 Q36503299-F824A6E4-1EFE-41A1-AF38-2D95B9BABA25 Q37133483-13EE405C-65FB-46CE-8A8D-0C22C704813C Q37370730-7D1C387F-F724-4354-BDFD-4677AB030800 Q37432092-E7EBFB79-B01B-4046-9E48-BF2615A4ACEA Q42725944-F669539A-2DA9-4491-BA4F-CAA976FE91D5 Q43035123-36E843B3-E593-4FF5-B87A-D2AE21384B41 Q43039469-E0800689-F93A-45A7-AECB-72402DBCA47D Q43040750-283B8A3F-FE60-452E-BEDA-0E5F75B00F65 Q43040863-8D9715FC-0EB6-4966-AA54-B2AD89C5E37D Q43047734-4D591FA4-5B3D-4AC4-A186-972C3F606B13 Q58725798-95A1BC38-435D-45D0-99BA-3DA34FC0E19C

P2860

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

http://www.wikidata.org/entity/Q27477966

description

2003 nî lūn-bûn

@nan

2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@ast

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@en

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@nl

type

label

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@ast

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@en

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@nl

prefLabel

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@ast

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@en

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@nl

P1433

Q27477966-3A75226F-5734-49B8-87A7-C3B5E6F2E4D5

P1476

Q27477966-2DA35BDF-9BAA-45A2-AFA8-9F9B7E86238F

P2093

Q27477966-12040F5C-BA16-448E-B0E9-D98EFB0B69B9

Q27477966-293622AF-A621-4E22-A6BE-DA72D5F84FB0

Q27477966-323B5CCD-BCA3-4031-9AF7-EB5221216095

Q27477966-347B6B22-1457-4A11-94E6-77F62418EC63

Q27477966-555CA29A-B5EB-49F3-A627-5DFD984FFF27

Q27477966-71E37D88-7C0F-4544-B1F6-B819466C634A

Q27477966-74F73667-0AEB-48F4-89F4-6E1D4CDABF3A

Q27477966-82900E1F-80A4-4325-8D13-C7917ACBE466

Q27477966-95FC06C2-7387-4A30-8BC3-E26B9741B722

Q27477966-9EE88766-D6A1-4E5C-B061-FB01E3F202ED

P2860

Q27477966-2D8C7A07-0A6A-426F-BF86-035CEA35AE4F

Q27477966-2DBEA2CB-6057-4C6A-88E3-EA7961962B32

Q27477966-36FD0B06-B6C2-43AE-B03E-56F844034991

Q27477966-3B6D869D-0BE1-4727-BA00-904AAE7930AF

Q27477966-3DA39595-4425-44AE-BE33-732E37031F27

Q27477966-558FCE94-4CEC-4A85-9DC9-3F43C1966759

Q27477966-58131D66-5B6C-4D31-85C4-DF13B1241F03

Q27477966-7BA006C2-D349-42DE-8639-C7C3E8F934F8

Q27477966-891F01BC-800F-44A6-96BF-B131167572F0

Q27477966-8C0A98D4-5EEC-4618-AF5E-5A2278C10AC8

P304

Q27477966-39D95C9D-DF9D-4940-B95C-ADCD2DAEF9EB

P31

Q27477966-9BBB16FB-ABE7-4918-B6A4-6067DA99B2D3

P3181

Q27477966-5CD68A87-4F58-4961-B88F-926162985388

P356

Q27477966-4F22D6E5-5E0B-4B8E-858E-41EDD8ABEA03

P407

Q27477966-63DBBBD0-815C-4E97-A283-67185527379C

P433

Q27477966-AE26A08C-E152-4DE8-A68D-8BFFF2C1E03F

P478

Q27477966-33156526-14A9-4B26-A9E6-9E1DF5F0791C

P577

Q27477966-C425A59A-00E3-4234-A514-915EAEA83AF8

P5875

Q27477966-73878625-0139-4638-A07B-B0CB2C187757

P698

Q27477966-232416F8-F381-4E93-BB51-BDE22E69F295

P921

Q27477966-176AB502-8D9E-4042-ADFB-6951E3096D40

P932

Q27477966-853AAAAC-7014-4CB1-A3BC-852F90BD87E3

P3181

P356

P1433

P1476

Liver fibrosis is not associat ...... ients with chronic hepatitis C

@en

P2093

C Degott

http://www.w3.org/2001/XMLSchema#string

D Cazals-Hatem

http://www.w3.org/2001/XMLSchema#string

D Valla

http://www.w3.org/2001/XMLSchema#string

D Vidaud

http://www.w3.org/2001/XMLSchema#string

F Tubach

http://www.w3.org/2001/XMLSchema#string

H Daïkha

http://www.w3.org/2001/XMLSchema#string

K Nahon

http://www.w3.org/2001/XMLSchema#string

M Martinot

http://www.w3.org/2001/XMLSchema#string

M Vidaud

http://www.w3.org/2001/XMLSchema#string

M-C Guimont

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

Liver fibrosis in overweight patients

Steatohepatitis: a tale of two "hits"?

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Epidemiology of hepatitis C: geographic differences and temporal trends

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

Fibrosis and disease progression in hepatitis C.

P304

1638-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1370422

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/GUT.52.11.1638

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231585995

http://www.w3.org/2001/XMLSchema#string

P698

14570735

http://www.w3.org/2001/XMLSchema#string

P921

P932

1773870

http://www.w3.org/2001/XMLSchema#string